Search
for
Sort by
Research 181–210 of 526
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Medications
- The role of lymphocytes in the development and treatment of alopecia areata
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Ritlecitinib: First Approval
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Oxidative stress and alopecia areata
- New therapies for alopecia areata
- Hair Dermal papilla maintain its hair inducing characteristics via autocrine exosomal miR-23a-3p
- 916 Gynecologic and hormonal comorbidities of scarring alopecia: A retrospective review
- British Society for Dermatopathology
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review